1. miR-19 promotes osteosarcoma progression by targeting SOCS6
    Zhengwen Sun et al, 2018, Biochemical and Biophysical Research Communications CrossRef
  2. Bone Cancer: Dysregulation of Signaling Cascades by microRNAs
    Janaina de Andréa Dernowsek, 2018, Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs CrossRef
  3. A Novel Predictive Model Associated with Osteosarcoma Metastasis
    Han Zhang et al, 2021, Cancer Management and Research CrossRef
  4. miR-486-5p expression is regulated by DNA methylation in osteosarcoma
    Heidi M. Namløs et al, 2022, BMC Genomics CrossRef
  5. The clinical utility of dysregulated microRNA expression in paediatric solid tumours
    Karan R. Chadda et al, 2022, European Journal of Cancer CrossRef
  6. Comparison of Oncogenes, Tumor Suppressors, and MicroRNAs Between Schizophrenia and Glioma: The Balance of Power
    James S. Brown, 2023, Neuroscience & Biobehavioral Reviews CrossRef
  7. Multifunctional nanomaterials via cell cuproptosis and oxidative stress for treating osteosarcoma and OS-induced bone destruction
    Lin Ye et al, 2024, Materials Today Bio CrossRef
  8. Downregulation of miR‑486‑5p in papillary thyroid carcinoma tissue: A study based on microarray and miRNA sequencing
    Dong‑Yue Wen et al, 2018, Molecular Medicine Reports CrossRef
  9. miRNA signatures in childhood sarcomas and their clinical implications
    G. M. Viera et al, 2019, Clinical and Translational Oncology CrossRef

  10. Elevated Expression of miR-629 Predicts a Poor Prognosis and Promotes Cell Proliferation, Migration, and Invasion of Osteosarcoma


    Xuesen Li et al, 2020, OncoTargets and Therapy CrossRef
  11. miR‑486 acts as an oncogene and potential prognostic biomarker in renal cell carcinoma
    Chengwen Sun et al, 2019, Molecular Medicine Reports CrossRef
  12. miR-486 is involved in the pathogenesis of acute myeloid leukemia by regulating JAK-STAT signaling
    Cao Sha et al, 2021, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
  13. Analysis of miRNA-mRNA Crosstalk in Radiation-Induced Mouse Thymic Lymphomas to Identify miR-486 as a Critical Regulator by Targeting IGF2BP3 mRNA
    Hainan Zhao et al, 2021, Frontiers in Oncology CrossRef
  14. Novel insights into the multifaceted roles of m6A-modified LncRNAs in cancers: biological functions and therapeutic applications
    Jinxin Tang et al, 2023, Biomarker Research CrossRef
  15. Development and validation of neutrophil extracellular traps-derived signature to predict the prognosis for osteosarcoma patients
    Yunhua Lin et al, 2024, International Immunopharmacology CrossRef
  16. MiRNAs as Novel Adipokines: Obesity-Related Circulating MiRNAs Influence Chemosensitivity in Cancer Patients
    Sarah B. Withers et al, 2020, Non-Coding RNA CrossRef
  17. miR-340 alleviates chemoresistance of osteosarcoma cells by targeting ZEB1
    Haibin Yan et al, 2018, Anti-Cancer Drugs CrossRef
  18. Long noncoding RNA SLC9A3‑AS1 increases E2F6 expression by sponging microRNA‑486‑5p and thus facilitates the oncogenesis of nasopharyngeal carcinoma
    Jiansheng Li et al, 2021, Oncology Reports CrossRef
  19. miR-486 inhibited osteosarcoma cells invasion and epithelial-mesenchymal transition by targeting PIM1
    Yuhan Liu et al, 2018, Cancer Biomarkers CrossRef
  20. Long non-coding RNA ZFAS1 sponges miR-486 to promote osteosarcoma cells progression and metastasis in vitro and vivo
    Nan Li et al, 2017, Oncotarget CrossRef
  21. The correlation analysis of miRNAs and target genes in metastasis of cervical squamous cell carcinoma
    Jing Zhou et al, 2018, Epigenomics CrossRef
  22. MicroRNA copy number alterations in the malignant transformation of pleomorphic adenoma to carcinoma ex pleomorphic adenoma
    Talita de Carvalho Kimura et al, 2024, Head & Neck CrossRef
  23. Exosome‑delivered miR‑486‑3p inhibits the progression of osteosarcoma via sponging CircKEAP1/MARCH1 axis components
    Huidong Yang et al, 2023, Oncology Letters CrossRef